Guillain-Barré syndrome

Guillain-Barré syndrome is the most common and most severe acute paralytic neuropathy, with about 100 000 people developing the disorder every year worldwide. Under the umbrella term of Guillain-Barré syndrome are several recognisable variants with distinct clinical and pathological features. The se...

Full description

Saved in:

Bibliographic Details
Published in:	The Lancet (British edition) Vol. 388; no. 10045; pp. 717 - 727
Main Authors:	Willison, Hugh J, Jacobs, Bart C, van Doorn, Pieter A
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 13.08.2016 Elsevier Limited
Subjects:	Axons - immunology Axons - pathology Biomarkers Campylobacter Infections - complications Campylobacter Infections - immunology Campylobacter jejuni Clinical Trials as Topic Diagnosis, Differential Disease Management Electrophysiology Epidemiology Guillain-Barre syndrome Guillain-Barre Syndrome - complications Guillain-Barre Syndrome - diagnosis Guillain-Barre Syndrome - epidemiology Guillain-Barre Syndrome - immunology Guillain-Barre Syndrome - physiopathology Guillain-Barre Syndrome - therapy Humans Immunoglobulins, Intravenous - therapeutic use Infections Influenza Vaccines - administration & dosage Influenza Vaccines - adverse effects Internal Medicine Medical prognosis Muscle Weakness - complications Muscle Weakness - etiology Neural Conduction - immunology Neuropathology Paralysis - complications Paralysis - immunology Plasma Exchange Plasmapheresis Prognosis Respiratory Insufficiency - etiology Respiratory Insufficiency - prevention & control Treatment Outcome Vaccines
ISSN:	0140-6736, 1474-547X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!